Paul Perco
Paul Perco
Home
Experience
Accomplishments
Skills
Light
Dark
Automatic
1
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Synthetic lethality guiding selection of drug combinations in ovarian cancer
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft function
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma
Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes
Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis
Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer
Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer
«
»
Cite
×